Aspartoacylase suppresses prostate cancer progression by blocking LYN activation.
Weng H, Xiong KP, Wang W, Qian KY, Yuan S, Wang G, Yu F, Luo J, Lu MX, Yang ZH, Liu T, Huang X, Zheng H, Wang XH.
Weng H, et al. Among authors: liu t.
Mil Med Res. 2023 Jun 5;10(1):25. doi: 10.1186/s40779-023-00460-0.
Mil Med Res. 2023.
PMID: 37271807
Free PMC article.